Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Spectrum of chronic gastrointestinal diseases with final outcome in children at a tertiary care centre: A single-centre study.

Authors:
Iqtadar Seerat Muhammad Atique Eitzaz Uddin Khan

J Pak Med Assoc 2022 Jun;72(6):1188-1192

Department of Anaesthesia, Pakistan Kidney and Liver Institute and Research Centre, Lahore, Pakistan.

Chronic gastrointestinal (GI) diseases in children present with a wide range of symptoms. Limited resources in Paediatric Gastroenterology in developing countries like Pakistan cause considerable difficulties in managing children with chronic GI diseases in a timely fashion. This retrospective descriptive study aimed to determine the spectrum and outcomes of chronic GI diseases in children. The study was conducted at the Paediatric Gastroenterology and Hepatology Department, Pakistan Kidney and Liver Institute & Research Centre (PKLI &RC) in Lahore. The duration of the study was from August 2019 to August 2020. A total of 40 children below the age of 15 years with chronic GI diseases were included. The diagnosis was principally established with the assistance of esophagogastroduodenoscopy and ileo-colonoscopy. Coeliac disease was the most common chronic GI disease. Our systematic approach, in addition to an extensive workup, assisted in the diagnosis and management of the illness, which resulted in a more optimal outcome. Prompt referrals to tertiary centres are recommended where facilities and expertise are available to decrease morbidity and mortality.

Download full-text PDF

Source
http://dx.doi.org/10.47391/JPMA.3546DOI Listing
June 2022

Publication Analysis

Top Keywords

chronic diseases
12
gastrointestinal diseases
8
diseases children
8
paediatric gastroenterology
8
chronic gastrointestinal
8
diseases
5
children
5
chronic
5
included diagnosis
4
diseases included
4
years chronic
4
age years
4
children age
4
total children
4
2020 total
4
august 2020
4
2019 august
4
august 2019
4
children study
4
study august
4

Keyword Occurance

Similar Publications

Optimising breathlessness triggered services for older people with advanced diseases: a multicentre economic study (OPTBreathe).

Authors:
Deokhee Yi Charles C Reilly Gao Wei Irene J Higginson

Thorax 2022 Aug 15. Epub 2022 Aug 15.

Cicely Saunders Institute of Palliative Care, Policy and Rehabilitation, King's College London, London, UK

Background: In advanced disease, breathlessness becomes severe, increasing health services use. Breathlessness triggered services demonstrate effectiveness in trials and meta-analyses but lack health economic assessment.

Methods: Our economic study included a discrete choice experiment (DCE), followed by a cost-effectiveness analysis modelling. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Tobacco industry ownership of pharmaceutical companies: an international survey of people with respiratory disease.

Authors:
Ruth Tal-Singer Linda Walsh Tim Deuby Angela Shaughnessy Karin F Hoth Victor Gascon Susanne Hintringer Nicole Hass Tonya Winders Lucy Morgan Byron Thomashow David M Mannino

Thorax 2022 Aug 15. Epub 2022 Aug 15.

COPD Foundation, Miami, Florida, USA.

The 2021 purchase of the respiratory pharmaceutical company Vectura by Phillip Morris International has been criticised by the public health and medical community, as a conflict of interest, with little input to date, from the patient community or the public. To address this gap, the COPD Foundation, along with global partners, surveyed 1196 people with chronic respiratory disease. 70% were bothered by a tobacco company making an inhaler to treat lung conditions and 48% reported that they would want to switch inhalers if they knew that a tobacco company made or sold their inhaler devices. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Pediatric Sarcoidosis: Retrospective Analysis of Biopsy-proven Patients.

Authors:
Kerstin Nott Veronica Nott Elliot Lever Claire Deakin James Galloway Corinne Fisher Sandrine Compeyrot-Lacassagne

J Rheumatol 2022 Aug 15. Epub 2022 Aug 15.

Rheumatology Department, Great Ormond Street Hospital for Children, London, United Kingdom (UK), Imperial College School of Medicine, London, UK, Department of Adolescent Rheumatology, University College London Hospitals NHS Foundation Trust, London, UK, Centre for Adolescent Rheumatology Versus Arthritis at University College London, University College London Hospital and Great Ormond Street Hospital, London, UK, National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, UK, Infection, Immunity and Inflammation Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK, Centre for Rheumatic Diseases, Kings College, London, UK, National Institute for Health Research Biomedical Research Centre, Great Ormond Street Hospital, London, UK. Corresponding author: Orcid ID - 0000-0001-9200-7450 Postal address: Dr. Kerstin Nott, Paediatric Rheumatology department Great Ormond Street Hospital for Sick Children, Great Ormond Street, London, WC1N 3JH, UK.

Objective: To describe the phenotype, disease course, and treatment of a large cohort of children with sarcoidosis.

Methods: Patients with biopsies consistent with sarcoidosis, performed between 2010 and 2020, were included. Patients' notes were reviewed retrospectively. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Relapse and Remission in Children With Chronic Noninfectious Uveitis Treated With Methotrexate.

Authors:
Courtney McCracken Jessica G Shantha Steven Yeh Kirsten Jenkins Kelly A Rouster-Stevens Scott R Lambert Sampath Prahalad Carolyn Drews-Botsch Sheila T Angeles-Han

J Rheumatol 2022 Aug 15. Epub 2022 Aug 15.

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia; Francis I. Proctor Foundation for Research in Ophthalmology, and Department of Ophthalmology University of California, San Francisco, San Francisco, California; Department of Ophthalmology, University of Nebraska Medical Center, Omaha, Nebraska; Children's Healthcare of Atlanta, Atlanta, Georgia; Department of Ophthalmology, Stanford University, Stanford, California; Department of Genetics, Emory University School of Medicine, Atlanta, Georgia; Department of Global and Community Health, George Mason University, Fairfax, Virginia; Division of Rheumatology and Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.C. McCracken and J.G. Shantha contributed equally to this work. Research reported in this manuscript was supported by the National Eye Institute (NEI) Award Number K23EY021760 (STAH), K23EY030159 ( JGS), and the Rheumatology Research Foundation. STAH is also supported by NEI R01EY030521. SP is supported in part by a grant from the Marcus Foundation Inc., Atlanta. SY is a consultant for Santen and Clearside Biomedical, unrelated to this study. KARS is a consultant for Accordant, unrelated to this study. SP serves on the Macrophage Activation Syndrome Adjudication Committee for Novartis and is a Doximity Op-Med Fellow for 2021-22, unrelated to this study. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. S.T. Angeles-Han, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, 3333 Burnett Avenue, Cincinnati, OH 45229, USA; Department of Pediatrics, University of Cincinnati, Cincinnati, OH 45229, USA. Email:

Pediatric chronic noninfectious uveitis (NIU) can lead to sight-threatening complications and often requires long-term immunosuppression. Uveitis occurs in isolation (ie, idiopathic NIU), or is associated with systemic diseases, most commonly juvenile idiopathic arthritis (JIA). Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial.

Authors:
Philip J Thompson Gerard J Criner Mark T Dransfield David M G Halpin MeiLan K Han David A Lipson Ghassan J Maghzal Fernando J Martinez Dawn Midwinter Dave Singh Lee Tombs Robert A Wise

Respirology 2022 Aug 15. Epub 2022 Aug 15.

Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Background And Objective: Chronic mucus hypersecretion (CMH) is a clinical phenotype of COPD. This exploratory post hoc analysis assessed relationship between CMH status and treatment response in IMPACT.

Methods: Patients were randomized to once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) 100/62. Read More

View Article and Full-Text PDF
August 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap